This archive includes all weekly updates of the figures on the COVID-19 vaccination programme in the Netherlands.

8 June 2021 | 16:50 PM

Vaccination figures: 31 May to 6 June 2021

By Sunday 6 June, it is estimated that more than 10.7 million vaccinations had been administered in the Netherlands. More than 7.3 million of those were first vaccinations, and 3.4 million were second vaccinations.  The daily number of doses administered is posted on the Coronavirus Dashboard.

Vaccination turnout by age group

More than 50% of people over the age of 18 have received a first vaccination. Vaccination turnout in people over 65 is between 83% and 93% for the first vaccination. Turnout among people under 60 is rising quickly as the campaign moves forward. Turnout for the first vaccination has now reached 71% for people aged 55-59 and 50% for people aged 50-54. Vaccination turnout for people aged 45-49 and 40-45 is now at 29% and 23%. 14% of people aged 35-39 years have now received a first vaccination.

Vaccination turnout by municipality

The figures for vaccination turnout by municipality among people over 65 years old clearly show that regional differences have grown even smaller. The number of municipalities with a turnout higher than 85% among people over 65 has continued to increase.

Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete. As a result, the actual turnout is somewhat higher.

Vaccinations with the Janssen vaccine are included in the vaccination reports from GGDGHOR as of this week. A technical change in the GGDGHOR reporting process had to be implemented to make that possible. In implementing that change, it became apparent that people who received only one vaccination after a previous COVID-19 infection had only been partially included in the figures reported by GGDGHOR and RIVMNational Institute for Public Health and the Environment . That oversight has been corrected, bringing the number of vaccinations reported by RIVM to nearly 160,000 more vaccinations than last week.

Vaccination figures 6 January to 6 June 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 22 (2021), by type of vaccinator.

Vaccinator Target group Start date1 First dose Second dose Total
GGD
  • People aged 90 and up
26 January 2021    68,156    63,434 131,590
GGD
  • 85-89 years
29 January 2021   189,904 177,652 367,556
GGD
  • 80-84 years
05 February 2021   377,326 354,659 731,985
GGD
  • 75-79 years
06 March 2021   571,939 532,996 1,104,935
GGD
  • 70-74 years
06 April 2021   858,675 735,629 1,594,304
GGD
  • 65-69 years
19 April 2021   775,989 341,508 1,117,497
GGD
  • 60-64 years
     65,740 48,069 113,809
GGD
  • 55-59 years
27 April 2021   826,332 73,505 899,837
GGD
  • 50 -54 years
20 May 2021   592,507 59.243 651,750
GGD
  • 45 - 49 years
26 May 2021    282,177 43,057 325,234
GGD
  • 40 - 44 years
29 May 2021    197,608 32,760 230,368
GGD
  • 35 - 39 years
     118,021 27,529 145,550
GGD
  • 30 - 34 years
     101,190  25,826 127,016
GGD
  • 25 - 29 years
      95,323  25,538 120,861
GGD
  • 20 - 24 years
     102,496   31,115 133,611
GGD
  • <20 years
      50,631 13,243 63,874
GGD
  • Age unknown
             976       263    1.239
Vaccinated by GPs (estimated)2,3   15 February 2021 1,228,601 432,044 1,660,645
Vaccinated by other vaccinators (estimated)   06 January 2021   869,315 383,740 1,253,055
Total     7,372,906 3,401,810 10,774,716

Footnote table:

COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.

1 The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.

2 A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.

3 Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.

4 For VAX, the same assumption is used as for vaccinations by general practitioners (see footnote 3). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).   From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.

5 166,141 estimated vaccinations administered by other vaccinators, and 217,994 vaccinations administered by the GGD, involved JANSS. This involves the first dose, since 1 dose of this vaccine is sufficient.


1 June 2021 | 16:50 PM

Vaccination figures: 24 to 30 May 2021

By Sunday 30 May, it is estimated that more than 9.3 million vaccinations had been administered in the Netherlands. More than 6.5 million of those were first vaccinations, and 2.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. The actual number of doses administered is about 78,000 higher than presented in the current overview. This is due to the data registered by the Municipal Public Health Services (GGDs) regarding the Janssen vaccine, which has been rolled out for vaccination since 28 May; this data has not yet been processed.

Vaccination turnout
As of this week, turnout will no longer be calculated solely on the basis of GGD data, but will also be supplemented with data from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete; this applies in particular to people aged 60-64 years who are vaccinated by their GP. As a result, the actual turnout is likely to be somewhat higher. 

Vaccination turnout among people over 65 varies somewhat per age group, ranging from 82% to 92% for the first vaccination. Turnout for the first vaccination has now reached 59% for people aged 50-54 and 25% for people aged 50-54. On average, 87% of people aged 65 years and older have now had their first vaccination. RIVM published figures on vaccination turnout last Friday.

Turnout per municipality

Regional differences are minimal. Turnout in most municipalities is above 75%, and frequently higher than 85%.

 

Vaccination figures 6 January to 30 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 21 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,905    62,934 130,839
  • 85-89 years
29 January 2021     189,202 176,321 365,523
  • 80-84 years
05 February 2021     375,683 352,054 727,737
  • 75-79 years
06 March 2021     567,149 522,095 1,089,244
  • 70-74 years
06 April 2021     828,936 564,086 1,393,022
  • 65-69 years
19 April 2021     728,180 120,218 848,461
  • 60-64 years
       63,461 47,051 110,512
  • 55-59 years
27 April 2021     678,160 60,859 739,019
  • 50 -54 years
20 May 2021     279,132 52,675 313,807
  • 45 - 49 years
26 May 2021      175,291 38,122 213,413
  • 40 - 44 years
29 May 2021      121,894 28,975 150,869
  • 35 - 39 years
       97,225 24,409 121,634
  • 30 - 34 years
       86,961 23,038 109,999
  • 25 - 29 years
       81,829 23,146 104,975
  • 20 - 24 years
       87,838 28,663 116,501
  • <20 years
       41,950 12,210 54,160
  • Age unknown
            868      202      1,070
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601  300,383 1,528,984
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   851,812  367,570 1,219,382
Total     6,552,077 2,805,074 9,357,151

Footnote table:

  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP.  The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.  The vaccinations administered with the Janssen vaccine have not yet been included in these figures. This involves about 26,000 vaccinations a day. The Municipal Public Health Services (GGDs) started administering the Janssen vaccine on 28 May 2021. This means that the figures for the vaccinations administered by the GGD are underreported by about 78,000 vaccinations.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  5. 156,277 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.

25 May 2021 | 16:15 PM

Vaccination figures: 17 to 23 May 2021

By Sunday 23 May, it is estimated that more than 8.4 million vaccinations had been administered in the Netherlands. More than 6.1 million of those were first vaccinations, and 2.3 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Vaccination coverage based on GGD data
The number of people vaccinated by the GGD is rising rapidly every week. Vaccination coverage among people aged 55-59 has risen to 42% for the first vaccination. Vaccination coverage for people aged 50-54 has been included for the first time, and has now reached 16% for the first vaccination.

Vaccination coverage among people over 65 living at home has also increased and varies somewhat per age group, ranging from 73% to 91% for the first vaccination. Coverage in these age groups continues to rise slightly every week. People aged 60-64 years are not included in these charts displaying GGD data, since that age group is primarily vaccinated by their GPs.

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 23 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 19 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,802    62,198 130,000
  • 85-89 years
29 January 2021     188,890 174,689 363,579
  • 80-84 years
05 February 2021     374,898 347,665 722,563
  • 75-79 years
06 March 2021     563,578 460,534 1,024,112
  • 70-74 years
06 April 2021     813,695 336,600 1,150,295
  • 65-69 years
19 April 2021     717,866 40,202 758,068
  • 60-64 years
       62,067 42,376 104,443
  • 55-59 years
27 April 2021     525,395 51,648 577,043
  • 50 -54 years
20 May 2021     204,613 44,783 249,398
  • 45 - 49 years
       140,507 32,300 172,807
  • 40 - 44 years
       101,353 24,239 125,592
  • 35 - 39 years
       81,381 20,383 101,764
  • 30 - 34 years
       73,234 19,370 92.604
  • 25 - 29 years
       69,031 19,610 88,641
  • 20 - 24 years
       74,600 24,246 98,846
  • <20 years
       34,312 10,444 44,756
  • Age not specified
            833      147       980
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601  226,737 1,455,338
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   830,697  366,391 1,197,088
Total     6,153,355 2,304,562 8,457,917
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. 
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  5. 142,069 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.

 


18 May 2021 | 16:15 PM

Vaccination figures: 10 to 16 May 2021

By Sunday 16 May, it is estimated that more than 7.4 million vaccinations had been administered in the Netherlands. More than 5,6 million of those were first vaccinations, and nearly 1.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Vaccination coverage based on GGD data 
As of this week, charts displaying vaccination coverage will be provided again. They show vaccination coverage per age group based on the data provided by the Municipal Public Health Services (GGDs). The number of people vaccinated by the GGD is now rising rapidly every week. Among people aged 65 years and older living at home, vaccination coverage is now over 70% for the first vaccination and is still increasing. Vaccination coverage among all people over 65 is higher than what is being reported based on GGD figures, because this group also includes people in residential institutions and people who were vaccinated by their GP. People aged 60-64 years are not included in these charts. This age group is mainly vaccinated by their GPs, and the data records on those vaccinations are not yet complete.

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 16 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 19 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,584    61,386 128,970
  • 85-89 years
29 January 2021     188,360   172,739   361,099
  • 80-84 years
05 February 2021     373,439   341,726   715,165
  • 75-79 years
06 March 2021     558,072   322,516   880,588
  • 70-74 years
06 April 2021     802,828   146,983   949,811
  • 65-69 years
19 April 2021     704,934    16,417   721,351
  • 60-64 years
       60,773    40,814   101,587
  • 55-59 years
27 April 2021     359,812    49,536   409,348
  • 50 -54 years
      126,847    42,794   169,641
  • 45 - 49 years
       90,420    30,659   121,079
  • 40 - 44 years
       67,020    22,730    89,750
  • 35 - 39 years
       55,203    19,036    74,239
  • 30 - 34 years
       50,781    18,153    68,934
  • 25 - 29 years
       48,235    18,256    66,491
  • 20 - 24 years
       54,660    22,797    77,457
  • <20 years
       23,777     9,912    33,689
  • Age not specified
         770      128      898
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601    90,322 1,318,923
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   799,914   359,995 1,159,909
Total     5,662,030 1,786,899 7,448,929
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. 2.    The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on) and people who would normally be eligible for the influenza vaccination (from 6 May 2021). The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021), inhabitants of the Wadden Islands (from 16 February 2021), and people who would normally be eligible for the influenza vaccination. Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. 
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19.
  5. 124,373 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other 

 


11 May 2021 | 16:30 PM

Vaccination figures: 3 to 9 May 2021

By Sunday 9 May, it is estimated that more than 6.4 million vaccinations had been administered in the Netherlands. Almost 5 million of those were first vaccinations, and over 1.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Last week, GPs started administering the second vaccination, primarily to people aged 60-64 years. People over 65 who did not respond to the invitation for vaccination earlier can still make an appointment: Calling all people over 65: make a vaccination appointment now

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
 

Vaccination figures 6 January to 9 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 18 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 67,112 60,713 127,825
  • 85-89 years
29 January 2021 COM 186,785 170,996 357,781
  • 80-84 years
05 February 2021 COM 370,079 336,728 706,807
  • 75-79 years
06 March 2021 COM 550,946  230,068 781,014
  • 70-74 years
06 April 2021 COM 783,223     49,591 832,814
  • 65-69 years
19 April 2021 COM 592,880     13,810 606,690
  • 60-64 years
diverse COM/AZ  59,357      36,918    96,275
  • 55-59 years
27 April 2021    173,845      43,875 217,720

Other people vaccinated by the GGD

06 January 2021 COM/AZ 353,256 156,965 510,221
Vaccinated by GPs (estimated)3 15 February 2021 AZ 1,115,125       41,945 1,157,070
Vaccinated by other vaccinators (estimated)3,4,5 06 January 2021 COM/MOD/AZ/JANSS 738,620 329,659  1,068,279
Total     4,991,228 1,471,268 6,462,496
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) will vaccinate people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups) and care workers. The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). The GGD already started vaccinating care workers from 6 January on. In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are therefore not the entire age group who are living at home, but primarily care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution for week 18 is assumed to be 60% first dose and 40% second dose for AZ vaccinations administered by GPs.
  5. 95,466 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other 

04 May 2021 | 17:00 PM

Vaccination figures: 26 April to 2 May 2021

By Sunday 2 May, it is estimated that more than 5.6 million vaccinations had been administered in the Netherlands. More than 4.4 million of those were first vaccinations, and over 1.2 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Number of vaccinations given

The update for the past week shows the number of vaccinations that have been given. This report now also includes the age groups of 55-59 years and 60-64 years among the groups vaccinated by the Municipal Public Health Services (GGDs). Within the latter age group, people are usually vaccinated by their GPs, but in special situations may be vaccinated by the GGD. This could include care workers or people living on the Wadden Islands.

This weekly update is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 2 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 17 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 66,623 60,006 126,629
  • 85-89 years
29 January 2021 COM 184,976 169,095 354,071
  • 80-84 years
05 February 2021 COM 367,143 329,635 696,778
  • 75-79 years
06 March 2021 COM 542,819  133,453 676,272
  • 70-74 years
06 April 2021 COM 744,418     4,738 749,156
  • 65-69 years
19 April 2021 COM 360,019    12,404 372,423
  • 60-64 years
diverse COM/AZ   58,296    32,415    90,711
  • 55-59 years
27 April 2021     89,310    37,814 127,124

Other people vaccinated by the GGD

06 January 2021 COM/AZ 318,505 130,806 449,311
Vaccinated by GPs (estimated)3 15 February 2021 AZ 1,052,207               0 1,052,207
Vaccinated by other vaccinators (estimated)3,4,5 06 January 2021 COM/MOD/AZ/JANSS 664,414 292,747  957,161
Total     4,448,730 1,203,113 5,651,843
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. Vaccinations for older people are being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices. This is arranged when people are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups). In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021) who have been vaccinated by the GGD with the AstraZeneca vaccine or Comirnaty®. People born in 1955, 1954 and 1953 (aged 65-67 years) who are living in the provinces of Groningen, Friesland, Drenthe, Overijssel, Noord-Holland and Zeeland may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. Since we cannot identify these people separately, they have been included in this category.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. 8,883 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  5. Up to and including week 12, deliveries to care institutions that involved the same product (brand name and storage conditions) that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 53,506 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17, this assumption is applied for all vaccinators except for the GGD and GPs, and is not applied for AZ. It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

20 April 2021 | 16:00 PM (revision 28-04-2021)

Vaccination figures: 12 to 18 April 2021

By Sunday 18 April, it is estimated that more than 4.3 million vaccinations had been administered in the Netherlands. Almost 3.4 million of those were first vaccinations, and almost 1 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Number of vaccinations given
The update for week 15 shows the number of vaccinations that have been given. This is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Number of vaccine doses delivered
The number of doses of COVID-19 vaccines delivered to the Netherlands will now be displayed on the Coronavirus Dashboard.

Vaccination figures 6 January to 18 April 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 15 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 65,393 58,372 123,765
  • 85-89 years
29 January 2021 COM 181,906 162,770 344,676
  • 80-84 years
05 February 2021 COM 360,218 289,845 650,063
  • 75-79 years
06 March 2021 COM 474,724  37,456 512,180
  • 70-74 years
06 April 2021 COM 355,683     2,423 358,106

Other people vaccinated by the GGD

06 January 2021 COM/AZ 458,394 208,146 666,540
Vaccinated by GPs (estimated)3 15 February 2021 AZ 862,524               0 862,524
Vaccinated by other vaccinators (estimated)3,4 06 January 2021 COM/MOD/AZ 605.016 235.085 840,101
Total     3.363.858 994.097 4,357,955
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently being used, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed from week 13 on that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca). In principle, these assumptions have not been changed for the period from week 1 through 12 and can be found in the report of 30 March 2021; however, the projected wastage for these first 12 weeks has been retroactively reduced from 5% to 1%. This estimate is updated frequently as more information becomes available.
  4. Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 48,057 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).    It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

13 April 2021 | 10:30 PM (revision 28-04-2021)

Vaccination figures: 5 to 11 April 2021

The COVID-19 vaccination figures published today in the RIVM report and on the Corona Dashboard are higher than in previous weeks. The news item about the vaccination figures provides further details on this increase.
By Sunday 11 April, it is estimated that nearly 3.5 million vaccinations had been administered in the Netherlands. Almost 2.7 million of those were first vaccinations, and over 900,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Number of vaccinations given

The update for week 14 shows the number of vaccinations that have been given. This is based on the number of vaccinations administered by the GGD and estimates based on the number of doses delivered to other vaccinators.

Number of vaccine doses delivered

In week 14, the Netherlands received 487,890 doses of the Pfizer/BioNTech vaccine and 55,440 doses of the AstraZeneca vaccine.

Vaccination figures 6 January to 11 April 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 14 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 64,514 56,751 121,265
  • 85-89 years
29 January 2021 COM 179,931 156,123 336,054
  • 80-84 years
05 February 2021 COM 354,126 241,389 595,515
  • 75-79 years
06 March 2021 COM 339,357 16,927 356,284
  • 70-74 years
06 April 2021 COM  158,082 2,007 160,089

Other people vaccinated by the GGD

06 January 2021 COM/AZ 428,410 205,150 633,560
Vaccinated by GPs (estimated)3 15-02-2021 AZ 583,254               0 583,254
Vaccinated by other vaccinators (estimated)3,4 06-01-2021 COM/MOD/AZ 553.078 225.164 778,242
Total     2.660.752 903.511 3,564,263
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
  4. Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 36,033 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).     It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

09 April 2021 | 18:15 PM

Weekly update on COVID-19 vaccination: 29 March to 4 April 2021

By Sunday 4 April, it is estimated that more than 2.8 million vaccinations had been administered in the Netherlands. In week 13, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine, 145,200 doses of the Moderna vaccine and 430,320 doses of the AstraZeneca vaccine.

The update for week 13, like previous weekly updates, provides estimates of the total number of vaccinations administered based on the number of vaccines delivered. However, it is no longer possible for all vaccinators to distinguish between the total number of first and second doses. This is because the same target groups can now receive both their first vaccination and second vaccination. It is also no longer possible to calculate vaccination coverage for elderly people living at home, since vaccinations for this group are now being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices.  RIVM is currently only receiving complete information on the number of vaccinations administered to people who were vaccinated by the GGD. 

A daily estimate of the number of vaccinations that have been administered is available on the Coronavirus Dashboard provided by the Dutch national government.

Vaccination figures 6 January to 4 April 2021

Table: Number of people who received a first and possibly also second dose of COVID-19 vaccine, 1 January to 4 April 2021, by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Thuiswonende ouderen gevaccineerd door de GGD2          
  • People aged 90 and up
26 January 2021 COM 63.731 54.566 118.297
  • 85-89 years
29 January 2021 COM 177.945 145.706 323.651
  • 80-84 years
05 February 2021 COM 346.431 157.544 503.975
  • 75-79 years
06 March 2021 COM 242.759    7.303 250.062
  • 70-74 years
06 April 2021 COM  54.790    1.670  56.460

Other people vaccinated by the GGD

06 January 2021 COM/AZ 423.573 202.057 625.630
Vaccinated by GPs (estimated)3 15-02-2021 AZ 331.774               0 331.774
Vaccinated by other vaccinators)3,4 06-01-2021 COM/MOD/AZ 416.559 237.578 654.137
Totaal     2.057.562 806.424 2.863.986
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
  4. From week 13 onwards, no distinction can currently be made between first and second doses for vaccinations carried out by other vaccinators, and the first and second doses are allocated pro rata based on the distribution up to and including week 12 for other vaccinators (i.e. 64% first dose, 36% second dose). That distinction can be made again once the national registration system (CIMS) can be used to generate reports.

30 March 2021 | 16:00 PM

Weekly update on COVID-19 vaccination: 21 to 28 March 2021

By Sunday 28 March, it is estimated that nearly 1.7 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 700,000 people had received their second vaccination. 

Vaccination coverage

The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 68% for the first vaccination and 55% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 79% for the first vaccination and 57% for the second. For people aged 80-84 living at home, vaccination coverage is at 82% for the first vaccination and 24% for the second. Vaccination coverage for the first COVID-19 jab has risen to 23% of people aged 75-79 living at home. 

Vaccination coverage is no longer increasing as rapidly in the over-80 age groups. People in these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD), by calling the national appointment scheduling centre; the phone number is provided in the invitation letter. 
Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province. The GPs in Drenthe will receive extra vaccines for this group at the end of this week. Next week, deliveries will be made to GPs in North Holland, Overijssel, Groningen and Friesland. Other provinces will then start vaccinating eligible people living at home who are unable to travel, once enough vaccines have been delivered to supply those doses as well. 

Vaccine deliveries

In the past week, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine and 44,880 doses of the AstraZeneca vaccine.

Reporting

RIVMNational Institute for Public Health and the Environment will soon start posting updates on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS). 
 

Vaccination figures 6 January to 28 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   14,050
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 400,946 201,123
Living at home        
90 years and up living at home 26-01-2021 COM  62,986 50,953
85-89 years 29-01-2021 COM 175,827 127,491
80-84 years 05-02-2021 COM 338,640 97,129
75-79 years 06-03-2021 COM  144,754 4,400
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 198,945        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 199,827 149,497
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  112,265 5,419
Total     1,688,490

690,062

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
  • As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.

23 March 2021 | 16:15 PM

Weekly update on COVID-19 vaccination: 14 to 21 March 2021

By Sunday 21 March, it is estimated that nearly 1.5 million people in the Netherlands had received at least one COVID-19 vaccination, and more than 600,000 people had received their second vaccination. The 2 millionth vaccination was administered last week, on 19 March.

Vaccination with the AstraZeneca vaccine was temporarily on hold, which affected last week’s vaccination figures. As a result of the temporary hold, people aged 60-64, people with Down’s syndrome, people with morbid obesity, and patients and employees in mental healthcare institutions and in long-term care were not vaccinated with the AstraZeneca vaccine last week. Vaccination with the AstraZeneca vaccine started again this week.

Vaccination coverage

The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 67% for the first vaccination and 48% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 78% for the first vaccination and 45% for the second vaccination. Vaccination coverage among people aged 80-84 living at home has risen to 80% for the first vaccination and 13% for the second vaccination. Vaccination coverage for the first COVID-19 jab has risen to 15% of people aged 75-79 living at home. 

Most people in the over-80 age groups have received their vaccination(s). Vaccination coverage in these age groups is increasing less rapidly than in the first weeks after vaccination started. There are people in these age groups who have not yet been vaccinated. It is important for people in these age groups who want to be vaccinated to schedule an appointment as soon as possible. Everyone in these older age groups can now schedule a vaccination appointment with the Municipal Public Health Service (GGD). They can make an appointment by calling the national appointment scheduling centre; the phone number is provided in the invitation letter. In the very near future, GPs will start providing vaccinations for elderly people living at home who are not mobile enough to come to the GGD. 

Vaccine deliveries

In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine, 44,880 doses of the AstraZeneca vaccine, and 96,000 doses of the Moderna vaccine.

Reporting

RIVMNational Institute for Public Health and the Environment will soon start reporting on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS). Based on the data in CIMS, it will be possible to show vaccination coverage by age group, region, municipality and gender. It will still be possible to display a breakdown of vaccination figures based on which vaccine brand was administered and which type of implementing party administered it. The breakdown by target group (care workers, general practitioners, institutional residents and people at high risk for severe COVID-19) will no longer be provided.
 

Vaccination figures 6 January to 21 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   14,050
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 360,417 198,194
Living at home        
90 years and up living at home 26-01-2021 COM  62,328 44,874
85-89 years 29-01-2021 COM 173,620 99,124
80-84 years 05-02-2021 COM 328,646 51,984
75-79 years 06-03-2021 COM    94,649 2,349
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 154,803        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 171,929 149,497
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  91,797     5,419
Total     1,492,489

605,491

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
  • As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.

16 March 2021 | 16:10 PM

Weekly update on COVID-19 vaccination: 8 to 14 March 2021

By Sunday 14 March, it is estimated that nearly 1.4 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 500,000 people had received their second vaccination.

Vaccination coverage
The preliminary COVID-19 vaccination coverage for people over 90 living at home has risen to 66% for the first vaccination and 37% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 76% for the first vaccination and more than 21% for the second vaccination. Vaccination coverage for the first COVID-19 jab has reached 74% of people aged 80-84 living at home, and 7% of people aged 75-79 living at home.

People from these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD). Vaccination will also start shortly for non-mobile elderly people living at home who cannot come to the GGD for an appointment. 

Vaccine deliveries
In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine and 95,040 doses of the AstraZeneca vaccine. There were no vaccine deliveries from Moderna in the past week. 
 

Vaccination figures 6 January to 14 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   13,300
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 356,972 196,083
Living at home        
90 years and up living at home 26-01-2021 COM  61,258 34,345
85-89 years 29-01-2021 COM 169,045 47,681
80-84 years 05-02-2021 COM 305,321 5,713
75-79 years 06-03-2021 COM    44,066    572
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 154,803        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 168,241 150,010
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  80,597     5,419
Total     1,394,603

493,123

content footnote

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

09-03-2021 | 16:30 uur

Vaccinatiecijfers 28 februari tot en met 7 maart 2021

Tot en met zondag 7 maart hebben naar schatting ruim 1,2 miljoen mensen in Nederland tenminste één coronavaccinatie ontvangen en ruim 400.000 mensen een tweede vaccinatie.

Vaccinatiegraad

De voorlopige vaccinatiegraad onder de thuiswonende 90-plussers staat op 64% voor de eerste vaccinatie en op 12% voor de tweede vaccinatie. De vaccinatiegraad onder thuiswonende 85-89-jarigen voor de eerste vaccinatie is 73% en bij de thuiswonende 80-84-jarigen is dat 63%. Onder de thuiswonende 75-79-jarigen is er een klein aandeel van 3% dat een eerste vaccinatie heeft gehad.

De leeftijdsgroep 75-79-jarigen ontvangt sinds afgelopen week een uitnodiging. Een klein aantal heeft iets eerder een eerste vaccinatie ontvangen. Het kan gaan om mensen die gelijk met de groep 80-84-jarigen zijn uitgenodigd, maar die toen nog net geen 80 waren en inwoners van de Waddeneilanden.

Toegeleverde vaccins

In de afgelopen week heeft Nederland 208.260 doses vaccin van BioNTech/Pfizer toegeleverd gekregen en van AstraZeneca 216.480 doses. Moderna heeft in de afgelopen week geen vaccins geleverd.

Vaccinatiecijfers 6 januari t/m 7 maart 2021

Doelgroep Startdatum Vaccin Eerste dosis Tweede dosis

Directe COVID-19-zorgmedewerkers

06-01-2021 COM   40.000 40.000

Huisartsen

22-01-2021 MOD 14.300 8.300
Andere zorgmedewerkers & thuiswonende ouderen <75 jaar 06-01-2021 COM/AZ 304.991 195.581
Thuiswonenden        
  • 90-plussers
26-01-2021 COM 59.162 11.421
  • 85-89-jarigen
29-01-2021 COM 161.916 1.376
  • 80-84-jarigen
05-02-2021 COM 259.307 338
  • 75-79 jarigen 
06-03-2021 COM 19.259 289
  • 60-64-jarigen & hoog risico ernstig beloop COVID-19 (schatting)
15-02-2021 AZ 120.674 0
Bewoners instellingen voor langdurige zorg (schatting)        
  • Verpleeghuizen en zorginstellingen met instellingsarts & GGZ geestelijke gezondheidszorg 
18-01-2021 COM/MOD/AZ 162.603 149.711
  • Kleinschalige woonvormen vallend onder huisarts
25-01-2021 MOD/COM 65.692 4.919
Totaal     1.207.904 411.935
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

02-03-2021 | 16:45 PM

Weekly update on COVID-19 vaccination: 21 to 28 February 2021

By Sunday 28 February, it is estimated that more than 1,000,000 people in the Netherlands had received at least one COVID-19 vaccination.

Vaccination started last week for mental health clients in inpatient or residential care at four large institutions and the mental healthcare workers employed there; they are being vaccinated by the institution’s own medical department. District nurses also started receiving their vaccinations last week.

Vaccination coverage among elderly people living at home has increased. The first COVID-19 jab for those living at home has been given to 61% of people over 90, 68% of people aged 85-89, and 42% of people aged 80-84. These percentages will increase even more in the next few weeks, when more people from these groups have received their vaccinations.

Second vaccination
More than 331,000 people are estimated to have received their second vaccination.

Vaccine deliveries
In the past week, the Netherlands received 200,070 doses of the Pfizer/BioNTech vaccine, 72,000 doses of the Moderna vaccine and 148,390 doses of the AstraZeneca vaccine. 
 

Vaccination figures 6 January to 21 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD 14,300 3,000
Other care workers & older people living at home <80 years 06-01-2021 COM/AZ 297,919 192,556
90 years and up living at home 26-01-2021 COM 56,747 196
85-89 years 29-01-2021 COM 150,859 200
80-84 years 05-02-2021 COM 172,523 214
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 63,002 0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 156,477 92,988
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM 52,930 2,517
Total     1,004,757

331,671

  • ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

16-2-2021 | 16:00 PM

Weekly update on COVID-19 vaccination: 7 to 14 February 2021

By Sunday 14 February 2021, it is estimated that about 629,000 people in the Netherlands had received their first COVID-19 vaccination. Starting last week, the first care workers in disability care and rehabilitation care are receiving their first vaccination with the AstraZeneca vaccine. Nursing home staff who had not been able to schedule an appointment yet are also included in this round. 

GP practices also started vaccinations yesterday for the first people aged 60-64 and for people who have a high risk of severe illness resulting from COVID-19. In this round, this concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). They will also receive the AstraZeneca vaccine.

Second vaccination
More than 154,400 people are estimated to have received their second vaccination. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.

Vaccine deliveries
In the past week, the Netherlands received 159,120 doses of the Pfizer/BioNTech vaccine, 95,040 doses of the AstraZeneca vaccine and 38,400 doses of the Moderna vaccine.

Vaccination figures 6 January to 14 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

Nursing home staff/people aged 80+ living at home

06-01-2021 COM/AZ 414,776 97,616

GPs

22-01-2021 MOD 14,300 0
People living in long-term care institutions (estimated)        
People living in nursing homes and care institutions with an institutional physician  18-01-2021 COM 152,006 16,829
People living in small-scale residential facilities under GP care  25-01-2021 MOD 7,911 0
Total     628,993 154,445
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care. 
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions. 
  • Direct COVID-19 care and GPs: rounded figures. 
  • COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available. 
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home. 
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment . These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

9-2-2021 | 16:20 PM

Weekly update on COVID-19 vaccination: 1 to 7 February 2021

By Sunday 7 February, more than 500,000 people in the Netherlands had received their first COVID-19 vaccination. That also includes about 13,600 GPs. Last Friday, the first people in the age group from 80-84 years received an invitation to make an appointment for a COVID-19 vaccination at a Municipal Public Health Service (GGD).  

Second vaccination
More than 66,000 people have received their second vaccination. 40,000 of these are employed in hospital care directly related to COVID-19. This group is now fully vaccinated. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.

Vaccine deliveries
The Netherlands received the first vaccines from AstraZeneca last week: 79,200 doses. In addition, another 159,120 doses of the Pfizer/BioNTech vaccine were delivered in the past week.
 

Vaccination figures 6 January to 7 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

Nursing home staff/people aged 80+ living at home

06-01-2021 COM 294,633 26,409

GPs

22-01-2021 MOD 13,600 0
People living in long-term care institutions (estimated)        
People living in nursing homes and care institutions with an institutional physician  18-01-2021 COM 151,584 0
People living in small-scale residential facilities under GP care  25-01-2021 MOD 4,919 0
Total     504,736 66,409
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care. 
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions. 
  • Direct COVID-19 care and GPs: rounded figures. 
  • COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available. 
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home. 
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment  . These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

2-2-2021 | 17:55 PM

Weekly COVID-19 vaccination update: 25-31 January

By Sunday 31 January, 327,834 people in the Netherlands had received their first COVID-19 vaccination. 15,692 healthcare professionals have received their second COVID-19 vaccination by now. Last week, the Netherlands received 191,880 doses of the Pfizer/BioNTech vaccine and 19,200 doses of the Moderna vaccine. 

In addition to the target groups that are already being vaccinated, vaccination of people aged 90 years and up also started this past week. On Friday 29 January, the first people aged 85-89 years received an invitation to make a vaccination appointment at a GGD vaccination site. 

Second vaccination

With the vaccines that are currently in use, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2. In the week of 25 to 31 January, 13,500 care workers in acute COVID-19 care received a second vaccination. They are now fully vaccinated. The second vaccination round for nursing home employees also started last week.  

Vaccination figures 6 to 31 January 2021

Target group Start date Vaccine Number of people who have started vaccination Number of people who are fully vaccinated

Direct COVID-19 care

06-01-2021 COM   40,000 13,500

Nursing home staff/people aged 85+ living at home

06-01-2021 COM 186,008 2,192

GPs

22-01-2021 MOD 6,000 0
Long-term care institutions (estimated) 18-01-2021 COM/MOD 95,826 0
Total     327.834 15,692
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs rounded to thousands.
  • Vaccination started = one dose received
  • Fully vaccinated = has received the total number of doses recommended by the manufacturer for that vaccine brand. For the currently available vaccines, this is 2 doses. COM=Comirnaty® (Pfizer/BioNTech); MOD=COVID-19 Vaccine Moderna®.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between target groups. For that reason, the table displays the combined group designated ‘Nursing home staff / people aged 85+ living at home’.
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses delivered to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses delivered at the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment  . These doses are administered on the day of delivery itself and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

26-1-2021 | 17:01 PM

More than 160 thousand people vaccinated in total

During the week of 18 to 24 January, more than 80 thousand people were vaccinated. Most of these were mainly care workers. Residents of institutions for people with intellectual disabilities and nursing homes also received their first vaccination. All vaccinated people still need to receive a second vaccination for optimal protection. In total, more than 160,000 people had been vaccinated by 24 January.

As of 19 January, RIVMNational Institute for Public Health and the Environment is publishing a weekly update on figures from the COVID-19 vaccination programme. The coronavirus dashboard provided by the Dutch Government has also started publishing COVID-19 vaccination figures as of today. The RIVM report does not yet include figures on vaccinations in nursing homes and administered to GPs, because a continuous data flow has not yet been achieved.

Nursing home residents, people with intellectual disabilities living in an institution, and GPs

On Monday 18 January, vaccination started for residents of nursing homes and institutions for people with intellectual disabilities. They are receiving the Comirnaty® vaccine manufactured by Pfizer/BioNTech. Based on an initial inventory by RIVM among the 12 nursing homes and care institutions where vaccination has started, approximately 17,000 people have received vaccinations so far. That includes about 2,000 care workers. Vaccination of the first general practitioners (GPs) started on Friday 22 January. They are receiving the COVID-19 Vaccine® manufactured by Moderna. Vaccination roll-out for GPs is still ongoing.

New data

Reporting was expanded this week to include the doses of COVID-19 vaccines that have been delivered. In the week of 18 to 24 January, the Netherlands received 92,430 doses from manufacturer Pfizer/BioNTech. Over 200 thousand vaccinations will be administered this week. At this point, the percentage of vaccinated people in the Dutch population is not yet high enough to have a visible impact on the course of the epidemic.

Vaccination figures 6 to 24 januari 2021

Target group   As of Number of people who have started vaccination
Care workers     146,612
  Hospital employees in acute care 06-01-2021 40,000
  Nursing home employees 06-02-2021 106,612
Total     146,612

• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.


19-1-2021 | 16:22 uur

Weekly RIVM update on vaccination figures

As of today, RIVM will be publishing an update every Tuesday on figures from the COVID-19-vaccination programme. Initial figures on the number of vaccinations that have been administered will be reported this week. The data will be updated and supplemented in the next few weeks. Eventually, the data will also be available in open data sets and on the coronavirus dashboard provided by the Dutch Government.

The Netherlands started vaccinating on 6 January. By Sunday 17 January, nearly 77,000 care workers in total had received their first COVID-19 vaccination. In hospitals, some 40,000 care workers in acute care directly related to COVID-19 were vaccinated within a week and a half. In the same period, about 37,000 nursing home employees received a vaccine through the Municipal Public Health Services (GGDs).  These people were vaccinated with the Comirnaty® vaccine manufactured by Pfizer/BioNTech and will receive a second vaccination in the coming weeks. Based on the current figures, this has not yet had a visible effect on the course of the epidemic.

Vaccination figures 6 to 17 januari 2021

Target group   Number of people who have started vaccination
Care workers   77,000
  Hospital employees in acute care 40,000
  Nursing home employees 37,000
Total   77,000

• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.